Maternal and perinatal implications of the use of human recombinant erythropoietin

Background. The use of human recombinant erythropoietin (rHuEPO) in pregnant patients has been limited by the fear of eventual maternal and fetal repercussions (either direct or indirect). Methods. The authors present their experience with the use of rHuEPO during pregnancy, with two pregnant women...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta obstetricia et gynecologica Scandinavica 1996-05, Vol.75 (5), p.449-453
Hauptverfasser:	Braga, Jorge, Marques, Ricardo, Branco, Anabela, Gonçalves, Joaquim, Lobato, Luísa, Pimentel, Joao Pedro, Flores, Maria Manuel, Gonçalves, Eduardo, Jorge, Carlos Santos
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system chronic renal insufficiency Erythropoietin - adverse effects Female Fetus - drug effects human recombinant erithropoietin Humans Infant, Newborn Kidney Failure, Chronic - complications Male Medical sciences Pharmacology. Drug treatments Pregnancy Pregnancy Complications - chemically induced Pregnancy Complications - etiology Pregnancy Outcome Recombinant Proteins - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!